Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Improving Genomic Predictors of Drug Response through Meta-Analysis of Large Pharmacogenomic Datasets

EF 2016-17

Résumé
Selecting the best treatment for cancer patients remains a persisting challenge due to the heterogeneity of the disease. Large pharmacogenomic studies combine high throughput screening of cancer cell lines for drug response with molecular profiling of the same lines. These studies are conducted with the goal of discovering of predictive biomarkers of positive response, with a goal to enable the personalized treatment of cancer. Computational methods have been widely applied to the analysis of these studies, and have generated successfully validated predictions. However, the full use of the available data is hindered by inconsistencies in the reported data between different laboratories. Therefore, it is crucial to combine different studies in analysis to properly account for the unique technical noise and bias introduced by each laboratory. A meta-analysis of the current publicly available data has not been done, and the best method to combine the data from separate sources needs to be determined. The goal of this project is to develop and benchmark methods for the meta-analysis of pharmacogenomic studies. Ultimately, the meta-analysis should increase the reproducibility of discoveries made through pharmacogenomic studies, increasing confidence in the validity of the results as they are translated into clinical practice.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
367350
Name
Smirnov Petr
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Improving Genomic Predictors of Drug Response through Meta-Analysis of Large Pharmacogenomic Datasets
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Drug Repositioning; Machine Learning; Meta-Analysis; Pharmacogenomics; Translational Research
Abstract
Selecting the best treatment for cancer patients remains a persisting challenge due to the heterogeneity of the disease. Large pharmacogenomic studies combine high throughput screening of cancer cell lines for drug response with molecular profiling of the same lines. These studies are conducted with the goal of discovering of predictive biomarkers of positive response, with a goal to enable the personalized treatment of cancer. Computational methods have been widely applied to the analysis of these studies, and have generated successfully validated predictions. However, the full use of the available data is hindered by inconsistencies in the reported data between different laboratories. Therefore, it is crucial to combine different studies in analysis to properly account for the unique technical noise and bias introduced by each laboratory. A meta-analysis of the current publicly available data has not been done, and the best method to combine the data from separate sources needs to be determined. The goal of this project is to develop and benchmark methods for the meta-analysis of pharmacogenomic studies. Ultimately, the meta-analysis should increase the reproducibility of discoveries made through pharmacogenomic studies, increasing confidence in the validity of the results as they are translated into clinical practice.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Smirnov, Petr
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~